The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
The emerging roles of ARID1A in tumor suppression
Open accessAbstract
ARID1A has emerged as a tumor suppressor gene, which is mutated in a broad spectrum of cancers, especially in those arising from ectopic or eutopic endometrium. As a subunit of SWI/SNF chromatin remodeler, ARID1A facilitates target-specific binding of SWI/SNF complexes to chromatin, thereby altering the accessibility of chromatin to a variety of nuclear factors. In human cancer, ARID1A possesses not only features of a gatekeeper, regulating cell cycle progression, but also features of a caretaker, preventing genomic instability. An increasing body of evidence suggests crosstalk between ARID1A and PI3K/Akt pathways, and between ARID1A and p53. In this review, we discuss the spectrum of ARID1A alterations in cancers, tumor suppression mechanisms of ARID1A, oncogenic pathways cooperating with ARID1A, and clinical implications of ARID1A mutation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
The Biology of Chromatin Remodeling Complexes
Clapier, C. R., & Cairns, B. R. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.062706.153223 · Cited by 2,380
A signature motif in transcriptional co-activators mediates binding to nuclear receptors
Heery, D. M., Kalkhoven, E., Hoare, S., & Parker, M. G. (1997) · Nature · doi:10.1038/42750 · Cited by 2,128
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Self-citationGuichard, C., Amaddeo, G., Imbeaud, S., Ladeiro, Y., Pelletier, L., Maad, I. B., Calderaro, J., Bioulac-Sage, P., Letexier, M., Degos, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2256 · Cited by 1,453
MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
Treon, S. P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R. J., Patterson, C. J., Tripsas, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200710 · Cited by 1,294
SWI/SNF nucleosome remodellers and cancer
Wilson, B. G., & Roberts, C. W. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3068 · Cited by 1,282
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T.-L., Shih, I.-M., Mao, T.-L., Nakayama, K., Roden, R., Glas, R., Slamon, D., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,219
Self-citationChromatin remodelling during development
Ho, L., & Crabtree, G. R. (2010) · Nature · doi:10.1038/nature08911 · Cited by 1,114
ATP-dependent chromatin remodeling: genetics, genomics and mechanisms
Hargreaves, D. C., & Crabtree, G. R. (2011) · Cell Research · doi:10.1038/cr.2011.32 · Cited by 923
Fujimoto, A., Totoki, Y., Abe, T., Boroevich, K. A., Hosoda, F., Nguyen, H. H., Aoki, M., Hosono, N., Kubo, M., Miya, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2291 · Cited by 870
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Wang, K., Kan, J., Yuen, S. T., Shi, S. T., Chu, K. M., Law, S., Chan, T. L., Kan, Z., Chan, A. S. Y., Tsui, W. Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.982 · Cited by 771
Melanoma genome sequencing reveals frequent PREX2 mutations
Berger, M. F., Hodis, E., Heffernan, T. P., Deribe, Y. L., Lawrence, M. S., Protopopov, A., Ivanova, E., Watson, I. R., Nickerson, E., Ghosh, P., et al. (2012) · Nature · doi:10.1038/nature11071 · Cited by 756
Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
Self-citationDulak, A. M., Stojanov, P., Peng, S., Lawrence, M. S., Fox, C., Stewart, C., Bandla, S., Imamura, Y., Schumacher, S. E., Shefler, E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2591 · Cited by 735
Role of DNA Mismatch Repair Defects in the Pathogenesis of Human Cancer
Peltomäki, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.060 · Cited by 706
Jiao, Y., Pawlik, T. M., Anders, R. A., Selaru, F. M., Streppel, M. M., Lucas, D. J., Niknafs, N., Guthrie, V. B., Maitra, A., Argani, P., et al. (2013) · Nature Genetics · doi:10.1038/ng.2813 · Cited by 684
Zang, Z. J., Cutcutache, I., Poon, S. L., Zhang, S. L., McPherson, J. R., Tao, J., Rajasegaran, V., Heng, H. L., Deng, N., Gan, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2246 · Cited by 616
The Spectrum of SWI/SNF Mutations, Ubiquitous in Human Cancers
Shain, A. H., & Pollack, J. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055119 · Cited by 576
The SWI/SNF complex and cancer
Reisman, D., Glaros, S., & Thompson, E. A. (2009) · Oncogene · doi:10.1038/onc.2009.4 · Cited by 568
Highly parallel identification of essential genes in cancer cells
Luo, B., Cheung, H. W., Subramanian, A., Sharifnia, T., Okamoto, M., Yang, X., Hinkle, G., Boehm, J. S., Beroukhim, R., Weir, B. A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810485105 · Cited by 547
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Bochar, D. A., Wang, L., Beniya, H., Kinev, A., Xue, Y., Lane, W. S., Wang, W., Kashanchi, F., & Shiekhattar, R. (2000) · Cell · doi:10.1016/s0092-8674(00)00030-1 · Cited by 546
Chan-on, W., Nairismägi, M.-L., Ong, C. K., Lim, W. K., Dima, S., Pairojkul, C., Lim, K. H., McPherson, J. R., Cutcutache, I., Heng, H. L., et al. (2013) · Nature Genetics · doi:10.1038/ng.2806 · Cited by 497
Guo, G., Sun, X., Chen, C., Wu, S., Huang, P., Li, Z., Dean, M., Huang, Y., Jia, W., Zhou, Q., et al. (2013) · Nature Genetics · doi:10.1038/ng.2798 · Cited by 482
Immune escape of tumors: apoptosis resistance and tumor counterattack
Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468
Guan, B., Wang, T.-L., & Shih, I.-M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1562 · Cited by 442
Self-citationARID1B is a specific vulnerability in ARID1A-mutant cancers
Helming, K. C., Wang, X., Wilson, B. G., Vazquez, F., Haswell, J. R., Manchester, H. E., Kim, Y., Kryukov, G. V., Ghandi, M., Aguirre, A. J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3480 · Cited by 418
Sausen, M., Leary, R. J., Jones, S., Wu, J., Reynolds, C. P., Liu, X., Blackford, A., Parmigiani, G., Diaz, L. A., Papadopoulos, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2493 · Cited by 414
Exome sequencing of hepatitis B virus–associated hepatocellular carcinoma
Huang, J., Deng, Q., Wang, Q., Li, K.-Y., Dai, J.-H., Li, N., Zhu, Z.-D., Zhou, B., Liu, X.-Y., Liu, R.-F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2391 · Cited by 385
Understanding the Words of Chromatin Regulation
Wu, J. I., Lessard, J., & Crabtree, G. R. (2009) · Cell · doi:10.1016/j.cell.2009.01.009 · Cited by 364
A Specificity and Targeting Subunit of a Human SWI/SNF Family-Related Chromatin-Remodeling Complex
Nie, Z., Xue, Y., Yang, D., Zhou, S., Deroo, B. J., Archer, T. K., & Wang, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.23.8879-8888.2000 · Cited by 300
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
McConechy, M. K., Ding, J., Senz, J., Yang, W., Melnyk, N., Tone, A. A., Prentice, L. M., Wiegand, K. C., McAlpine, J. N., Shah, S. P., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2013.107 · Cited by 288
Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma
Guan, B., Mao, T.-L., Panuganti, P. K., Kuhn, E., Kurman, R. J., Maeda, D., Chen, E., Jeng, Y.-M., Wang, T.-L., & Shih, I.-M. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318212782a · Cited by 286
Self-citationSomatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types
Jones, S., Li, M., Parsons, D. W., Zhang, X., Wesseling, J., Kristel, P., Schmidt, M. K., Markowitz, S., Yan, H., Bigner, D., et al. (2012) · Human Mutation · doi:10.1002/humu.21633 · Cited by 285
Mammalian SWI/SNF complexes facilitate DNA double‐strand break repair by promoting γ‐H2AX induction
Park, J., Park, E., Lee, H., Kim, S. J., Hur, S., Imbalzano, A. N., & Kwon, J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601291 · Cited by 278
BAF complexes facilitate decatenation of DNA by topoisomerase IIα
Dykhuizen, E. C., Hargreaves, D. C., Miller, E. L., Cui, K., Korshunov, A., Kool, M., Pfister, S., Cho, Y.-J., Zhao, K., & Crabtree, G. R. (2013) · Nature · doi:10.1038/nature12146 · Cited by 269
Lee, H., Park, J., Kim, S., Kwon, S., & Kwon, J. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.27 · Cited by 264
Yamamoto, S., Tsuda, H., Takano, M., Tamai, S., & Matsubara, O. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.189 · Cited by 259
Chromatin remodeling and cancer, part II: ATP-dependent chromatin remodeling
Wang, G. G., Allis, C. D., & Chi, P. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.004 · Cited by 254
Liang, H., Cheung, L. W. T., Li, J., Ju, Z., Yu, S., Stemke-Hale, K., Dogruluk, T., Lu, Y., Liu, X., Gu, C., et al. (2012) · Genome Research · doi:10.1101/gr.137596.112 · Cited by 241
Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell‐cycle control
Nagl, N. G., Wang, X., Patsialou, A., Van Scoy, M., & Moran, E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601541 · Cited by 236
Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas
Wiegand, K. C., Lee, A. F., Al‐Agha, O. M., Chow, C., Kalloger, S. E., Scott, D. W., Steidl, C., Wiseman, S. M., Gascoyne, R. D., Gilks, B., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2911 · Cited by 235
Shain, A. H., Giacomini, C. P., Matsukuma, K., Karikari, C. A., Bashyam, M. D., Hidalgo, M., Maitra, A., & Pollack, J. R. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114817109 · Cited by 221
Bosse, T., ter Haar, N. T., Seeber, L. M., Diest, P. J. V., Hes, F. J., Vasen, H. F., Nout, R. A., Creutzberg, C. L., Morreau, H., & Smit, V. T. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.96 · Cited by 204
The Quest for the 1p36 Tumor Suppressor
Bagchi, A., & Mills, A. A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2095 · Cited by 196
Jass, J. R. (2004) · Familial Cancer · doi:10.1023/b:fame.0000039849.86008.b7 · Cited by 171
Ayhan, A., Mao, T.-L., Seckin, T., Wu, C.-H., Guan, B., Ogawa, H., Futagami, M., Mizukami, H., Yokoyama, Y., Kurman, R. J., et al. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e31826b5dcc · Cited by 167
Self-citationBeghelli, S., Manzoni, G. D., Barbi, S., Tomezzoli, A., Roviello, F., Gregorio, C. D., Vindigni, C., Bortesi, L., Parisi, A., Saragoni, L., et al. (2006) · Surgery · doi:10.1016/j.surg.2005.08.021 · Cited by 148
Nagl, N. G., Patsialou, A., Haines, D. S., Dallas, P. B., Beck, G. R., & Morán, E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1225 · Cited by 145
Allo, G., Bernardini, M. Q., Wu, R., Shih, I., Kalloger, S. E., Pollett, A. F., Gilks, C. B., & Clarke, B. A. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.144 · Cited by 134
Self-citationMamo, A., Cavallone, L., Tüzmen, Ş., Chabot, C., Ferrario, C., Hassan, S. N., Edgren, H., Kallioniemi, O., Aleynikova, O., Przybytkowski, E., et al. (2011) · Oncogene · doi:10.1038/onc.2011.386 · Cited by 127
Cajuso, T., Hänninen, U. A., Kondelin, J., Gylfe, A. E., Tanskanen, T. J., Katainen, R., Pitkänen, E., Ristolainen, H., Kaasinen, E., Taipale, M., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28705 · Cited by 126
Inoue, H., Furukawa, T., Giannakopoulos, S., Zhou, S., King, D., & Tanese, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205961200 · Cited by 124
Genome profiling of pancreatic adenocarcinoma
Birnbaum, D. J., Adélaïde, J., Mamessier, E., Finetti, P., Lagarde, A., Monges, G., Viret, F., Gonçalvès, A., Turrini, O., Delpero, J., et al. (2011) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.20870 · Cited by 122
Dallas, P. B., Pacchione, S. J., Wilsker, D. F., Bowrin, V., Kobayashi, R., & Morán, E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3137-3146.2000 · Cited by 122
Emerging Epigenetic Targets and Therapies in Cancer Medicine
Popovic, R., & Licht, J. D. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0076 · Cited by 121
Nagl, N. G., Zweitzig, D. R., Thimmapaya, B., Beck, G. R., & Morán, E. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3427 · Cited by 120
Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma
Maeda, D., Mao, T., Fukayama, M., Nakagawa, S., Yano, T., Taketani, Y., & Shih, I. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11125120 · Cited by 116
Self-citationARID1a-DNA Interactions Are Required for Promoter Occupancy by SWI/SNF
Chandler, R. L., Brennan, J. A., Schisler, J. C., Serber, D., Patterson, C., & Magnuson, T. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.01008-12 · Cited by 116
BRCA1 participates in DNA decatenation
Lou, Z., Minter‐Dykhouse, K., & Chen, J. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb953 · Cited by 115
Mao, T., Ardighieri, L., Ayhan, A., Kuo, K., Wu, C., Wang, T., & Shih, I. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182889dc3 · Cited by 109
Self-citationGiulino-Roth, L. G., Wang, K., MacDonald, T. Y., Mathew, S., Tam, Y., Cronin, M. T., Palmer, G. A., Lucena‐Silva, N., Pedrosa, F. D. P. R., Pedrosa, M., et al. (2012) · Blood · doi:10.1182/blood-2012-06-437624 · Cited by 108
Modulation of Nucleotide Excision Repair by Mammalian SWI/SNF Chromatin-remodeling Complex
Zhao, Q., Wang, Q.-E., Ray, A., Wani, G., Han, C., Milum, K., & Wani, A. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.044982 · Cited by 107
Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer
Wang, D., Chen, Y.-B., Pan, K., Wang, W., Chen, S.-P., Chen, J.-G., Zhao, J.-J., Lv, L., Pan, Q., Li, Y.-Q., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040364 · Cited by 106
Abé, H., Maeda, D., Hino, R., Otake, Y., Isogai, M., Ushiku, A. S., Matsusaka, K., Kunita, A., Ushiku, T., Uozaki, H., et al. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1303-2 · Cited by 105
Wu, R., Ayhan, A., Maeda, D., Kim, K.-R., Clarke, B. A., Shaw, P. H., Chui, M. H., Rosen, B. P., Shih, I., & Wang, T. (2013) · The Journal of Pathology · doi:10.1002/path.4315 · Cited by 103
Self-citationGuan, B., Gao, M., Wu, C.-H., Wang, T., & Shih, I. (2012) · Neoplasia · doi:10.1593/neo.121218 · Cited by 101
Self-citationHuang, H., Lin, M.-C., Huang, W., Chiang, Y., & Kuo, K. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.216 · Cited by 99
Yamamoto, S., Tsuda, H., Takano, M., Tamai, S., & Matsubara, O. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1169-8 · Cited by 98
Streppel, M. M., Lata, S., delaBastide, M., Montgomery, E. A., Wang, J. S., Canto, M. I., Macgregor-Das, A. M., Pai, S. I., Morsink, F. H. M., Offerhaus, G. J. A., et al. (2013) · Oncogene · doi:10.1038/onc.2012.586 · Cited by 98
Lowery, W. J., Schildkraut, J. M., Akushevich, L., Bentley, R. C., Marks, J. R., Huntsman, D. D., & Berchuck, A. (2011) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e318231f140 · Cited by 96
Expression of p270 (ARID1A), a component of human SWI/SNF complexes, in human tumors
Wang, X., Nagl, N. G., Flowers, S. J., Zweitzig, D. R., Dallas, P. B., & Morán, E. (2004) · International Journal of Cancer · doi:10.1002/ijc.20450 · Cited by 95
Fadare, O., Gwin, K., Desouki, M. M., Crispens, M. A., Jones, H. W., Khabele, D., Liang, S. X., Zheng, W., Mohammed, K. S., Hecht, J. L., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.35 · Cited by 94
The DNA-binding properties of the ARID-containing subunits of yeast and mammalian SWI/SNF complexes
Wilsker, D. F. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh277 · Cited by 86
Wu, C. H., Mao, T., VANG, R. S., Ayhan, A., Wang, T., Kurman, R. J., & Shih, I. (2012) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31823f8482 · Cited by 86
Self-citationRole of the mammalian SWI/SNF chromatin remodeling complex in the cellular response to UV damage
Gong, F., Fahy, D., Liu, H., Wang, W., & Smerdon, M. J. (2008) · Cell Cycle · doi:10.4161/cc.7.8.5647 · Cited by 82
Genomic and functional evidence for an ARID1A tumor suppressor role
Huang, J., Zhao, Y., Li, Y., Fletcher, J. A., & Xiao, S. (2007) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20459 · Cited by 79
Flores‐Alcantar, A., Gonzalez‐Sandoval, A., Escalante‐Alcalde, D., & Lomelí, H. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1182-x · Cited by 76
Werner, H. M. J., Berg, A., Wik, E., Birkeland, E., Krakstad, C., Kusonmano, K., Petersen, K., Kalland, K. H., Oyan, A. M., Akslen, L. A., et al. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.174 · Cited by 75
The Chromatin Remodeling Gene ARID1A Is a New Prognostic Marker in Clear Cell Renal Cell Carcinoma
Lichner, Z., Scorilas, A., White, N. M. A., Girgis, A. H., Rotstein, L., Wiegand, K. C., Latif, A., Chow, C., Huntsman, D. D., & Yousef, G. M. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.007 · Cited by 73
Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity
Kothandapani, A., Gopalakrishnan, K., Kahali, B., Reisman, D., & Patrick, S. M. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.06.011 · Cited by 71
Krig, S. R., Miller, J. K., Frietze, S. E., Beckett, L. A., Neve, R. M., Farnham, P., Yaswen, P., & Sweeney, C. A. (2010) · Oncogene · doi:10.1038/onc.2010.289 · Cited by 71
Cho, H., Kim, J. S.-Y., Chung, H., Perry, C. D., Lee, H.-J., & Kim, J. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.11.007 · Cited by 65
ARID1A Alterations Are Associated with FGFR3-Wild Type, Poor-Prognosis, Urothelial Bladder Tumors
Balbás-Martínez, C., Rodriguez-Pinilla, M. S., Casanova, A., Domínguez, O., Pisano, D. G., Goméz-López, G., Lloreta, J., Lorente, J. A., Malats, N., & Real, F. X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062483 · Cited by 60
Zhang, X., Zhang, Y., Yang, Y., Niu, M., Sun, S., Ji, H., Ma, Y., Yao, G., Jiang, Y., Shan, M., et al. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.07.006 · Cited by 60
Mutations and deletions of ARID1A in breast tumors
Cornen, S., Adélaı̈de, J., Bertucci, F., Finetti, P., Guillé, A., Birnbaum, D. J., Birnbaum, D., & Chaffanet, M. (2012) · Oncogene · doi:10.1038/onc.2011.598 · Cited by 57
Fadare, O., Renshaw, I. L., & Liang, S. X. (2012) · Journal of Cancer · doi:10.7150/jca.4140 · Cited by 50
The genomic landscape of oesophagogastric junctional adenocarcinoma
Chong, I. Y.-S., Cunningham, D., Barber, L. J., Campbell, J., Chen, L., Kozarewa, I., Fenwick, K., Assiotis, I., Guettler, S., García-Murillas, I., et al. (2013) · The Journal of Pathology · doi:10.1002/path.4247 · Cited by 46
Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer
Rahman, M., Nakayama, K., Rahman, M. T., Katagiri, H., Katagiri, A., Ishibashi, T., Ishikawa, M., Iida, K., & Miyazaki, K. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.04.021 · Cited by 27
Katagiri, A., Nakayama, K., Rahman, M. T., Rahman, M., Katagiri, H., Ishikawa, M., Ishibashi, T., Iida, K., Otsuki, Y., Nakayama, S., et al. (2012) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e3182313d78 · Cited by 26
Zhang, L., Chen, H., Gong, M., & Gong, F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00007 · Cited by 24
Cited by
Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes
Mashtalir, N., D’Avino, A. R., Michel, B. C., Luo, J., Pan, J., Otto, J. E., Zullow, H. J., McKenzie, Z. M., Kubiak, R. L., St. Pierre, R., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.032 · Cited by 731
Shen, J., Ju, Z., Zhao, W., Wang, L., Peng, Y., Ge, Z., Nagel, Z. D., Zou, J., Wang, C., Kapoor, P., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0012-z · Cited by 562
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Shen, J., Peng, Y., Wei, L., Zhang, W., Yang, L., Lan, L., Kapoor, P., Ju, Z., Mo, Q., Shih, I.-M., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0849 · Cited by 522
“It has been found that ARID1A mutations cooperate with activation of the PI3K–AKT pathway in promoting tumorigenesis (2, 3).”
BackgroundSelf-citationThe Origin and Pathogenesis of Endometriosis
Wang, Y., Nicholes, K., & Shih, I.-M. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032654 · Cited by 455
Self-citationIntegrated Molecular Characterization of Uterine Carcinosarcoma
Cherniack, A. D., Shen, H., Walter, V., Stewart, C., Murray, B. A., Bowlby, R., Hu, X., Ling, S., Soslow, R. A., Broaddus, R. R., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.02.010 · Cited by 434
Metadata
- Authors
- Wu, R.-C., Wang, T.-L., & Shih, I.-M.
- Venue
- Cancer Biology & Therapy
- Publisher
- Informa UK Limited
- Published
- 2014-03-11
- Volume
- 15
- Issue
- 6
- Pages
- 655-664
- ISSN
- 1538-4047 (ISSN-L)
- 1555-8576
- OpenAlex
- W2068275655
- Cited by
- 261
- References
- 98
- FWCI
- 7.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.